Vident Investment Advisory, LLC Recursion Pharmaceuticals, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$4.56 - $9.94 $7,824 - $17,057
1,716 Added 10.64%
17,849 $133,000
Q1 2023

May 15, 2023
BUY
$6.42 - $9.64 $16,383 - $24,601
2,552 Added 18.79%
16,133 $107,000
Q4 2022

Feb 14, 2023
BUY
$7.16 - $12.7 $13,847 - $24,561
1,934 Added 16.61%
13,581 $104,000
Q3 2022

Nov 14, 2022
BUY
$7.83 - $13.6 $9,129 - $15,857
1,166 Added 11.12%
11,647 $124,000
Q2 2022

Aug 15, 2022
BUY
$5.04 - $9.26 $52,824 - $97,054
10,481 New
10,481 $85,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.41B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email